Scientists at UNC have developed a universal vaccine that protected mice not just against SARS-CoV-2, but also other coronaviruses, and triggered the immune system to fight...
By Matt Lauber, Joe Fredette, Colette Quinn, and Nick Zampa Sponsored content brought to you by The Emergence of mRNA for Vaccines and Therapy...
Researchers will evaluate antibody responses in vaccinated participants and their infants Credit: NIAID A new observational study has begun to evaluate the immune responses generated by...
AstraZeneca Plc’s. Covid-19 vaccine is effective against Delta and Kappa variants – which were first identified in India – the company said on June 22, citing a...
Could these health care stocks maintain their growth momentum? The post 4 Trending Health Care Stocks To Watch Right Now appeared first on Stock Market News,...
It didn’t take an expert to see that mRNA platforms could be huge. Julie Sunderland partnered with both Moderna and BioNTech about a decade ago while...
GlaxoSmithKline (GSK) has reported encouraging data for its COVID-19 antibody sotrovimab, and an alliance with Halozyme to develop The post Pair of R&D updates bolster GSK...
Vaccines Exhibit "Reduced Efficacy" Against "Delta" Variant, WHO Doctor Warns As the mutant COVID-19 strain known as "Delta" picks up steam across Europe and the US,...
Combination therapies appear to prevent emergence of drug resistance Credit: Matt Miller COVID-19 therapies made from antibodies often are given to patients who are at high...
GlaxoSmithKline and Vir Biotechnology said final results from a late-stage study of their monoclonal antibody confirmed sotrovimab significantly reduced hospitalization and death among high-risk Covid-19 patients...
Various companies use different ingredients and different delivery systems in their COVID-19 vaccines. Researchers are investigating whether it's better for individuals to mix what's available.
Vaccines have successfully curtailed viral diseases for decades. But as COVID-19 vaccination hesitancy shows, mistrust and misinformation continue to put lives at risk.
German biotech CureVac NV said the company's Covid-19 vaccine was only 47 percent effective in a late-stage trial, missing the study’s main goal and throwing in...
It’s harvest day for a pair of biotech startups with lofty goals to break new ground in cancer and coronary heart disease — and their high-profile...
CureVac has just had a harsh reminder of the perilous nature of drug development, after reporting that its COVID-19 vaccine candidate failed to achieve its endpoints...
People who cannot generate an effective immune response against COVID-19 can be protected with an infusion of Regeneron’s The post Regeneron drug saves lives in severe...
Early-stage companies advance precision medicine by applying AI, clinical genomics, and other new technologies. The post 10 Startups to Watch appeared first on Clinical OMICs -...
There are 36 cases of the so-called 'Nepal variant' in the UK.
AstraZeneca said a late-stage trial failed to provide evidence that the company's Covid-19 antibody therapy protected people who had contact with an infected person from the...
At least seven people in five U.S. states were infected with the novel coronavirus weeks before those states reported their first cases, a new government study...
As the field for monoclonal antibody treatments of Covid-19 grows more crowded, AstraZeneca has announced a study of its own cocktail AZD7442 did not meet its...
AZ’s COVID jab tackles delta variant, but antibody fails clinical trial appeared first on .
Novavax Inc. said vaccine efficacy appeared to be preserved in those receiving an approved influenza vaccine along with the company's Covid-19 vaccine candidate compared to those...
PREVENT-19 met a key exploratory endpoint of the study by showing 93.2% efficacy against both “variants of concern” (VoC) and “variants of interest (VoI). Variant data...
Upon regulatory approvals, Novavax said, it is on course to reach manufacturing capacity of 100 million doses per month by the end of the third quarter...
Gene expression patterns associated with pandemic viral infections provide a map to help define patients’ immune responses, measure disease severity, predict outcomes and test therapies —...
Public Health Officials Stumped As Southern States' Vaccination Rate Continues To Drag Less than a week ago, we reported that the US COVID-19 vaccination scheme had...
Check out these biotech players under the microscope now. The post Best Stocks To Invest In Right Now? 3 Biotech Stocks To Know appeared first on...
Scientists now understand the mechanism that leads to platelet activation and clotting Credit: McMaster University Hamilton, ON (June 9, 2021) – A new lifesaving treatment for...
Merck and Pfizer have been locked in a yearslong battle for a next-gen pneumococcal vaccine winner, with the latter looking to one-up — or should we...